News Menu

Day & night: Cancer disrupts the brain’s natural rhythm

Fluorescent microscopic image showing a keyhole-shaped dark area surrounded by green and blue speckled cells.
Borniger lab has found that breast cancer forces neurons (green) in a region of the mouse hypothalamus called the paraventricular nucleus (PVN), seen here, into a hyperactive state. This “always on” state knocks PVN neurons out of rhythm, blunting the body’s stress response to cancer.

“The brain is an exquisite sensor of what’s going on in your body,” says Cold Spring Harbor Laboratory Assistant Professor Jeremy Borniger. “But it requires balance. Neurons need to be active or inactive at the right times. If that rhythm goes out of sync even a little bit, it can change the function of the entire brain.”

In mice, the Borniger lab has found that breast cancer disrupts the diurnal, or day-night, rhythms of corticosterone levels. Corticosterone is the primary stress hormone in rodents. In humans, it’s cortisol. Typically, levels rise and fall naturally throughout the day. In breast cancer, the team found that tumors flatten corticosterone release, reducing quality of life and increasing mortality.

Disruptions to our own diurnal rhythms have been linked to stress responses like insomnia and anxiety—both common among cancer patients. The body depends on a feedback loop called the HPA axis to maintain healthy stress hormone levels. The hypothalamus (H), pituitary gland (P), and adrenal glands (A) work together to ensure regular day-night rhythms. Borniger was surprised to find that in mice, breast cancer can disrupt those rhythms before tumors take hold:

“Even before the tumors were palpable, we see about a 40 or 50% blunting of this corticosterone rhythm. We could see that happening within three days of inducing the cancer, which was very interesting.”

When the team looked at the hypothalamus, they saw that key neurons were locked into a hyperactive, yet low-output state. Once the team stimulated these neurons to mimic the mouse’s normal day-night cycle, regular stress hormone rhythms restarted. The adjustment pushed anti-cancer immune cells into breast tumors, causing them to shrink significantly. Borniger explains:

“Enforcing this rhythm at the right time of day increased the immune system’s ability to kill the cancer—which is very strange, and we’re still trying to figure out exactly how that works. The interesting thing is if we do the same stimulation at the wrong time of day, it no longer has this effect. So, you really need to have this rhythm at the right time to have this anti-cancer effect.”

The team is now investigating exactly how tumors disrupt the body’s healthy rhythms. Borniger hopes their work may one day help bolster existing therapies.

“What’s really cool is that we didn’t treat the mice with anti-cancer drugs,” he says. “We’re focused on making sure the patient is physiologically as healthy as possible. That itself fights the cancer. This might one day help boost the effectiveness of existing treatment strategies and significantly reduce the toxicity of many of these therapies.”

Written by: Nick Wurm, Communications Specialist | [email protected] | 516-367-5940


Funding

National Institutes of Health, National Cancer Institute, AACR Breast Cancer Research Foundation, Department of Defense, National Institute of Aging, Brain & Behavior Research Foundation, Howard Hughes Medical Institute, Rita Allen Foundation, McKnight Foundation, Simons Foundation, Klingenstein Fund

Citation

Gomez, A., et al., “Aberrant hypothalamic neuronal activity blunts glucocorticoid diurnal rhythms in murine breast cancer”, Neuron, December 15, 2025. DOI: 10.1016/j.neuron.2025.11.019

Core Facilites

Animal Tissue Imaging “The Animal Imaging Shared Resource provides researchers with both expertise and access to state-of-the-art, non-invasive preclinical imaging modalities. These include optical, ultrasound, CT, SPECT, and PET. These scanners collectively offer the researcher a high degree of experimental flexibility to non-invasively visualize and quantitate in vivo biology.” — Director Scott Lyons, Ph.D.

“The Flow Cytometry Shared Resource offers researchers equipment, training, and assistance with cellular analysis for a variety of applications as well as cell sorting. Our staff oversees equipment maintenance and quality control, trains new users on instrument operation, and assists with assay development and data analysis. We also provide tissue culture facilities for sample preparation and cell maintenance during ongoing flow cytometry experiments.” — Director Pamela Moody

image of the microscopy core facility icon “The Microscopy Core Facility provides training, consultation, experimental design and technical assistance to investigators at CSHL in widefield, spinning disk laser scanning or point laser scanning confocal fluorescence microscopy, and super-resolution microscopy. In addition, the Microscopy Shared Resource provides customized state-of-the-art optical imaging and quantitative image analysis applications to support a wide range of scientific endeavors.” — Director Erika Wee, Ph.D.

image of the sequencing core facility icon “The Sequencing Technologies and Analysis Shared Resource provides access to an array of high throughput Next Generation Sequencing (NGS) technologies. We offer cutting-edge technology alongside convenient in-house services for a broad range of genetic analysis.” — NGS Director Sara Goodwin, Ph.D.

Stay informed

Sign up for our newsletter to get the latest discoveries, upcoming events, videos, podcasts, and a news roundup delivered straight to your inbox every month.

  Newsletter Signup

Principal Investigator

Jeremy C. Borniger

Jeremy C. Borniger

Associate Professor
Cancer Center Member
Ph.D., Ohio State University, 2017

Tags